In yet another encouraging step toward the development of what could be the first drug approved for Alzheimer’s disease, the Federal Drug Administration today…
While most Alzheimer’s detection and prevention research is focused on the aggregation of tau tangles and amyloid beta proteins in the brain, some novel…
The latest news about Biogen’s controversial Alzheimer’s drug popped into my email at 8:26 a.m. last Wednesday. Coincidentally it arrived just as I was…
Hours feel like days. Days feel like months. And months? Well they can feel like a decade. Particularly when you are awaiting the restart…
An experimental “seaweed” drug called Oligomannate, which treats Alzheimer’s, is now available for patients to buy in China. Chinese officials announced conditional approval to…
Reporting on a procedure performed last year, scientists at the West Virginia University Rockefeller Neuroscience Institute said today that using low-intensity focused ultrasound is…